As of 2024-12-13, the Relative Valuation of ChromoGenics AB (CHRO.ST) is (39.45) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 9.78 SEK, the upside of ChromoGenics AB based on Relative Valuation is -503.4%.
The range of the Relative Valuation is (35.16) - (39.83) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 12.5x - 20.2x | 15.0x |
Forward P/E multiples | 12.0x - 14.2x | 13.1x |
Fair Price | (35.16) - (39.83) | (39.45) |
Upside | -459.5% - -507.3% | -503.4% |
Date | P/E |
2024-09-30 | -3.48 |
2024-09-27 | -3.48 |
2024-09-26 | -3.46 |
2024-09-25 | -3.47 |
2024-09-24 | -3.47 |
2024-09-23 | -3.48 |
2024-09-20 | -3.46 |
2024-09-19 | -3.48 |
2024-09-18 | -3.46 |
2024-09-17 | -3.51 |
2024-09-16 | -3.46 |
2024-09-13 | -3.48 |
2024-09-12 | -3.50 |
2024-09-11 | -3.44 |